21 related articles for article (PubMed ID: 4333001)
1. Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.
Watanabe N; Yamauchi N; Neda H; Maeda M; Tsuji Y; Okamoto T; Akiyama S; Sasaki H; Tsuji N; Niitsu Y
Jpn J Cancer Res; 1992 Jun; 83(6):638-43. PubMed ID: 1644666
[TBL] [Abstract][Full Text] [Related]
2. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
3. Effects of ulinastation on rat renal energy metabolism and blood flow in hemorrhagic shock.
Ueki M; Yokono S; Ogli K
J Anesth; 1995 Mar; 9(1):65-9. PubMed ID: 23839838
[TBL] [Abstract][Full Text] [Related]
4. Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate.
Rajakariar R; Newson J; Jackson EK; Sawmynaden P; Smith A; Rahman F; Yaqoob MM; Gilroy DW
J Immunol; 2009 Mar; 182(5):3262-9. PubMed ID: 19234224
[TBL] [Abstract][Full Text] [Related]
5. An adenosine triphosphate-dependent stabilization of proteolytic activity in heterolysosomes. Evidence for a proton pump.
Mego JL; Farb RM; Barnes J
Biochem J; 1972 Jul; 128(4):763-9. PubMed ID: 4629422
[TBL] [Abstract][Full Text] [Related]
6. Is the ATP-dependent protection of lysosomes against osmotic lysis a function of the lysosomal proton pump.
Ruth RC; Weglicki WB
Mol Cell Biochem; 1989 Oct; 90(2):165-73. PubMed ID: 2586496
[TBL] [Abstract][Full Text] [Related]
7. The effect of shock on blood oxidation-reduction potential.
Jellinek M; Chandel B; Abdulla R; Shapiro MJ; Baue AE
Experientia; 1992 Oct; 48(10):980-5. PubMed ID: 1426149
[TBL] [Abstract][Full Text] [Related]
8. Effect of adenosine triphosphate and some anti-inflammatory agents on a purified lysosomal fraction having high acid phosphatase and labile -glucuronidase activity.
Malbica JO; Hart LG
Biochem Pharmacol; 1971 Aug; 20(8):2017-26. PubMed ID: 4333001
[No Abstract] [Full Text] [Related]
9. Effects of anti-inflammatory drugs on the stability of rat liver lysosomes in vitro.
Ignarro LJ
Biochem Pharmacol; 1971 Oct; 20(10):2847-60. PubMed ID: 5114517
[No Abstract] [Full Text] [Related]
10. The effect of N,N,N'-tetramethylazoformamide (TMAF) on lysosomal stability in the presence and absence of anti-inflammatory agents.
Malbica JO
Biochem Biophys Res Commun; 1971 Sep; 44(6):1457-63. PubMed ID: 5160705
[No Abstract] [Full Text] [Related]
11. Dissimilar effects of anti-inflammatory drugs on stability of lysosomes from peritoneal and circulating leukocytes and liver.
Ignarro LJ
Biochem Pharmacol; 1971 Oct; 20(10):2861-70. PubMed ID: 5114518
[No Abstract] [Full Text] [Related]
12. Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases.
Ennis RS; Granda JL; Posner AS
Arthritis Rheum; 1968 Dec; 11(6):756-64. PubMed ID: 4302621
[No Abstract] [Full Text] [Related]
13. Effect of acetylsalicylic acid on lysosomes.
Miller WS; Smith JG
Proc Soc Exp Biol Med; 1966 Jul; 122(3):634-6. PubMed ID: 5918925
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
